循環器ジャーナル71巻4号

2023年10月発行

特集 変革期を迎えた肺高血圧症—次世代の病態理解，診断，治療とは？ Ⅲ.肺高血圧症における最新トピックス

治療抵抗性肺高血圧症に対する肺動脈自律神経叢除神経治療

著者： 浅野遼太郎¹ 大郷剛¹

所属機関： ¹国立循環器病研究センター肺循環科

ページ範囲：P.602 - P.607

POINT
●近年の肺血管拡張薬の発展は目覚ましいが，治療抵抗性の患者が一定数存在する．
●肺動脈周囲自律神経叢は肺動脈の収縮弛緩に関わっている．
●世界中で肺動脈自律神経叢を特異的に除神経するカテーテル治療開発が進められている．

参考文献

1）Vaillancourt M, Chia P, Sarji S, et al. Autonomic nervous system involvement in pulmonary arterial hypertension. Respir Res 2017 ; 18 : 201.

2）Chen SL, Zhang FF, Xu J, et al. Pulmonary artery denervation to treat pulmonary arterial hypertension : the single-center, prospective, first-in-man PADN-1 study（first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension）. J Am Coll Cardiol 2013 ; 62 : 1092-100.

3）Chen SL, Zhang H, Xie DJ, et al. Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes. Circ Cardiovasc Interv 2015 ; 8 : e002837.

4）Zlupko M, Harhay MO, Gallop R, et al. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med 2008 ; 102 : 1431-8.

5）Zandstra TE, Notenboom RGE, Wink J, et al. Asymmetry and Heterogeneity : Part and Parcel in Cardiac Autonomic Innervation and Function. Front Physiol 2021 ; 12 : 665298.

6）Maron BA, Leopold JA. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension : Part Ⅱ : Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension. Circulation 2015 ; 131 : 2079-91.

7）Zhang Y, Chen W, Xu Y, et al. Nerve distribution of canine pulmonary arteries and potential clinical implications. Am J Transl Res 2016 ; 8 : 365-74.

8）Rothman A, Jonas M, Castel D, et al. Pulmonary artery denervation using catheter-based ultrasonic energy. EuroIntervention 2019 ; 15 : 722-30.

9）Osorio J, Russek M. Reflex changes on the pulmonary and systemic pressures elicited by stimulation of baroreceptors in the pulmonary artery. Circ Res 1962 ; 10 : 664-7.

10）Ciarka A, Doan V, Velez-Roa S, et al. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med 2010 ; 181 : 1269-75.

11）Juratsch CE, Jengo JA, Castagna J, et al. Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature. Chest 1980 ; 77 : 525-30.

12）Chen SL, Zhang YJ, Zhou L, et al. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo. EuroIntervention 2013 ; 9 : 269-76.

13）Zhou L, Zhang J, Jiang XM, et al. Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline. JACC Cardiovasc Interv 2015 ; 8 : 2013-23.

14）Rothman AM, Arnold ND, Chang W, et al. Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension. Circ Cardiovasc Interv 2015 ; 8 : e002569.

15）Huang Y, Liu YW, Pan HZ, et al. Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension. Arterioscler Thromb Vasc Biol 2019 ; 39 : 704-18.

16）Hoeper MM, Galiè N. Letter by Hoeper and Galiè Regarding Article, “Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes : Phase Ⅱ Results From the Pulmonary Artery Denervation-1 Study”. Circ Cardiovasc Interv 2016 ; 9 : e003422.

17）Zhang H, Wei Y, Zhang C, et al. Pulmonary Artery Denervation for Pulmonary Arterial Hypertension. JACC Cardiovasc Interv 2022 ; 15 : 2412-23.

18）Zhang H, Zhang J, Chen M, et al. Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure : The PADN-5 Study. JACC Cardiovasc Interv 2019 ; 12 : 274-84.

19）Rothman AMK, Vachiery JL, Howard LS, et al. Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension（TROPHY1）. JACC Cardiovasc Interv 2020 ; 13 : 989-99.

20）Romanov A, Cherniavskiy A, Novikova N, et al. Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy. J Am Coll Cardiol 2020 ; 76 : 916-26.